RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice-Reference-Cited by-同舟云学术

RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice

Published:2016-11 Issue:48 Volume:291 Page:24838-24850
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Fujiwara Yuko,Piemontese Marilina,Liu Yu,Thostenson Jeff D.,Xiong Jinhu,O'Brien Charles A.

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference54 articles.

1. Genetic regulation of osteoclast development and function;Teitelbaum;Nat. Rev. Genet,2003

2. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis;Kong;Nature,1999

3. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development;Fata;Cell,2000

4. Control of RANKL gene expression;O'Brien;Bone,2010

5. The osteocyte: an endocrine cell … and more;Dallas;Endocr. Rev,2013

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caffeic acid derivative MPMCA suppresses osteoclastogenesis and facilitates osteoclast apoptosis: implications for the treatment of bone loss disorders;Aging;2024-08-26

2. Vitamin A enhanced periosteal osteoclastogenesis is associated with increased number of tissue-derived macrophages/osteoclast progenitors;Journal of Biological Chemistry;2024-06

3. Role of estrogen signaling in fibroblastic reticular cells for innate and adaptive immune responses in antigen‐induced arthritis;Immunology & Cell Biology;2024-05-10

4. Hematopoietic and stromal DMP1-Cre labeled cells form a unique niche in the bone marrow;Scientific Reports;2023-12-16

5. Targeting “Immunoporosis” as a novel concept of Immunotherapy in the management and treatment of Osteoporosis;Osteoporosis - Pathophysiology, Diagnosis, Management and Therapy [Working Title];2023-12-13